Document Detail


Botulinum toxin and pregnancy-a cautionary tale.
MedLine Citation:
PMID:  20521881     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 17-year-old female was treated with botulinum toxin (botulinum toxin type A, Allergan) for a left convergent squint. She returned 1 week after her second injection and informed us that she found out she was pregnant 3 days after the second injection. After a long worrying 9 months, her pregnancy fortunately proceeded to term with no adverse effect on both mother and baby. A literature review reassuringly suggests that it is a relatively safe treatment with no adverse effects on the expectant mother or the fetus. Up to 300 units of botulinum toxin have been used at various stages of pregnancy without adverse effects.
Authors:
J F T Li Yim; C R Weir
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Strabismus     Volume:  18     ISSN:  1744-5132     ISO Abbreviation:  Strabismus     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-04     Completed Date:  2010-09-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9310896     Medline TA:  Strabismus     Country:  England    
Other Details:
Languages:  eng     Pagination:  65-6     Citation Subset:  IM    
Affiliation:
Tennent Institute of Ophthalmology, Glasgow, UK. jamesly@doctors.org.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Botulinum Toxins / adverse effects*,  therapeutic use*
Female
Humans
Pregnancy
Pregnancy Complications / drug therapy*
Strabismus / drug therapy*
Chemical
Reg. No./Substance:
0/Botulinum Toxins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of horizontal rectus muscle surgery on clinical and eye movement recording indices in inf...
Next Document:  Treatment of Accommodative Insufficiency with Plus Lens Reading Addition: is +1.00 D Better than +2....